Prime Capital Investment Advisors LLC Reduces Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Prime Capital Investment Advisors LLC reduced its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 9.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,755 shares of the medical equipment provider’s stock after selling 594 shares during the quarter. Prime Capital Investment Advisors LLC’s holdings in Intuitive Surgical were worth $2,560,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in ISRG. Creekmur Asset Management LLC raised its holdings in Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 42 shares in the last quarter. Ridgewood Investments LLC purchased a new position in Intuitive Surgical in the second quarter valued at $26,000. Able Wealth Management LLC acquired a new position in Intuitive Surgical in the fourth quarter valued at $28,000. Delos Wealth Advisors LLC boosted its holdings in Intuitive Surgical by 380.0% in the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 57 shares in the last quarter. Finally, LRI Investments LLC acquired a new stake in Intuitive Surgical in the 1st quarter worth $30,000. Institutional investors own 83.64% of the company’s shares.

Intuitive surgical trading up 0.3%

NASDAQ ISRG opened at $491.39 on Tuesday. The stock has a market cap of $174.30 billion, a PE ratio of 88.70, a PEG ratio of 5.41 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $254.85 and a 12-month high of $496.18. The company’s 50-day moving average price is $464.67 and its 200-day moving average price is $422.79.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report ) last posted its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The firm had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. In the same quarter last year, the company posted earnings of $1.18 per share. The company’s revenue increased by 14.5% year-on-year. As a group, sell-side analysts estimate that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current year.

Insider trading at Intuitive Surgical

In related news, Director Amy L. Ladd sold 450 shares of Intuitive Surgical stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the sale, the director now directly owns 821 shares in the company, valued at $402,519.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible via this hyperlink. In related news, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction on Monday, July 29th. The shares were sold at an average price of $446.60, for a total transaction of $167,921.60. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,458,979.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available on the SEC’s website. Also, Director Amy L. Ladd sold 450 shares of Intuitive Surgical stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the transaction, the director now owns 821 shares in the company, valued at approximately $402,519.88. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 53,120 shares of company stock worth $25,528,753. 0.90% of shares are currently held by corporate insiders.

Changes in Analyst Ratings

ISRG has been the subject of a number of analyst research reports. Piper Sandler lifted their price objective on Intuitive Surgical from $490.00 to $495.00 and gave the company an “overweight” rating in a research report on Friday, July 19th. Evercore ISI cut their price objective on Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating on the stock in a research note on Friday, July 19th. Goldman Sachs Group began coverage on Intuitive Surgical in a report on Thursday, May 30th. They set a “buy” rating and a $500.00 price objective on the stock. Stifel Nicolaus upped their target price on shares of Intuitive Surgical from $430.00 to $475.00 and gave the company a “buy” rating in a report on Friday, July 19th. Finally, Robert W. Baird upped their target price on shares of Intuitive Surgical from $487.00 to $503.00 and gave the company an “outperform” rating in a research note on Friday, 19 July. Six investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Moderate Buy” and an average target price of $446.45, according to MarketBeat.com.

Get the latest stock analysis on ISRG

About Intuitive Surgical

(Free report)

Intuitive Surgical, Inc develops, manufactures and markets products that enable physicians and healthcare providers to improve the quality and access to minimally invasive care in the United States and internationally. The company offers the da Vinci surgical system that enables complex operations using a minimally invasive approach; and the Ion endoluminal system, which expands its commercial offerings beyond surgical interventions in diagnostic procedures that allow minimally invasive biopsies in the lungs.

Featured stories

Want to see what other hedge funds hold ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trading for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).

Get news and reviews for Intuitive Surgical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Intuitive Surgical and related companies with MarketBeat.com ‘s FREE daily email newsletter.